Pfizer (PFE)

EBITDA Margin

21.18%

TTM · Period ending:

PFE logo

PFE EBITDA Margin

Latest reported21.18%
PFE TTM EBITDA Margin (25.50% → 21.18%)
High-resolution chart · PNG

PFE ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Pfizer EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
35.6569%
33.9201%
35.6546%
36.4878%
38.9977%
46.1219%
40.4937%
38.1393%
35.767%
29.5609%
29.002%
30.6784%
29.4573%
29.4113%
30.3079%
30.7914%
31.4026%
30.8189%
30.5059%
30.3812%
29.6288%
29.6282%
28.8335%
28.0904%
27.3834%
27.2775%
27.3339%
17.6116%
17.2106%
19.6094%
18.7531%
28.2815%
27.881%
24.3%
23.6135%
22.5113%
22.1608%
21.9297%
21.554%
20.9786%
20.6481%
20.4133%
19.9781%
-35.92%
-19.3411%
-1.8471%
17.0713%
21.1371%
20.3384%
20.8244%
18.7897%
24.8167%
23.5895%
21.9513%
19.1227%
26.858%
24.748%
22.9473%
21.441%
28.0599%
25.4981%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.